mtDNA nt13708A variant increases the risk of multiple sclerosis

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Yu, Xinhua ^a   Koczan, Dirk ^a   Sulonen, Anna Maija ^b   Akkad, Denis A ^c   Kroner, Antje ^d   Comabella, Manuel ^e   Costa, Gianna ^f   Corongiu, Daniela ^f   Goertsches, Robert ^a   Camina Tato, Montserrat ^e   Thiesen, Hans Juergen ^a   Nyland, Harald I ^g,h   Mørk, Sverre J ^g   Montalban, Xavier ^e   Rieckmann, Peter ^d   Marrosu, Maria G ^f   Myhr, Kjell Morten ^g,h   Epplen, Joerg T ^c   Saarela, Janna ^b   Ibrahim, Saleh M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GUANINE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; ND5 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; EUROPE; FUNCTIONAL GENOMICS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POPULATION BASED CASE CONTROL STUDY; POPULATION STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; EPIDEMIOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; PHYSIOLOGY; RISK;

ALLELES; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; EPIDEMIOLOGY, MOLECULAR; EUROPE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIAL PROTEINS; MULTIPLE SCLEROSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 45349109162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001530     Document Type: Article

References (33)

1. Wallace DC (2001) Mitochondrial defects in neurodegenerative disease. Ment Retard Dev Disabil Res Rev 7: 158-166.
2. Kalman B, Lublin FD, Alder H (1997) Impairment of central and peripheral myelin in mitochondrial diseases. Mult Scler 2: 267-278.
3. Howell N, Elson JL, Chinnery PF, Turnbull DM (2005) mtDNA mutations and common neurodegenerative disorders. Trends Genet 21: 583-586.
4. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, et al. (1993) Mitochondrial DNA variants observed in Alsheimer disease and Parkinson disease patients. Genomics 17: 171-184.
5. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, et al. (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811.
6. Lecs F, Macdonald AM, Turner JW (1964) Leber's Disease with Symptoms Resembling Disseminated Sclerosis. J Neurol Neurosurg Psychiatry 27: 415-421.
7. Sadovnick AD, Bulman D, Ebers GG (1991) Parent-child concordance in multiple sclerosis. Ann Neurol 29: 252-255.
8. Ehers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, et al. (2004) Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 363: 1773-1774.
9. Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE (1994) Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 36: 109-112.
10. Kalman B, Lublin FD, Alder H (1995) Mitochondrial DNA mutations in multiple sclerosis. Mult Scler 1: 32-36.
11. Kalman B, Alder H (1998) Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis? Acta Neurol Scand 98: 232-237.
12. Kalman B, Li S, Chatterjee D, O'Connor J, Voehl MR, et al. (1999) Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 99: 16-25.
13. Houshmand M, Sanati MH, Babrzadeh F, Ardalan A, Teimori M, et al. (2005) Population screening for association of mitochondrial haplogroups BM,J, K and M with multiple sclerosis: interrelation between haplogroup J and MS in Persian patients. Mult Scler 11: 728-730.
14. Mihailova SM, Ivanova MI, Quin LM, Naumova EJ (2007) Mitochondrial DNA variants in Bulgarian patients affected by multiple sclerosis. Eur J Neurol 14: 44-47.
15. Pakendorf B, Stoneking M (2005) Mitochondrial DNA and human evolution. Annu Rev Genomics Hum Genet 6: 165-183.
16. Samuels DC, Carothers AD, Horton R, Chinnery PF (2006) The power to detect disease associations with mitochondrial DNA haplogroups. Am J Hum Genet 78: 713-720.
17. Torroni A, Lott MT, Cabell MF, Chen YS, Lavergne L, et al. (1994) mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 55: 760-776.
18. Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, et al. (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144: 1835-1850.
19. Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylha M, et al. (2003) Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 112: 29-33.
20. De Benedictis G, Rose G, Carrieri G, De Luca M, Falcone E, et al. (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. Faseb J 13: 1532-1536.
21. Reynier P, Penisson-Besnier I, Moreau C, Savagner F, Vielle B, et al. (1999) mtDNA haplogroup J: a contributing factor of optic neuritis. Eur J Hum Genet 7: 404-406.
22. Johns DR, Berman J (1991) Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Biochem Biophys Res Commun 174: 1324-1330.
23. Torroni A, Petrozzi M, D'Urbano L, Sellitto D, Zeviani M, et al. (1997) Haplotype and phylogenetic analyses suggest that one European-spepific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 60: 1107-1121.
24. Mohlke KL, Jackson AU, Scott LJ, Peck EC, Sub YD, et al. (2005) Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum Genet 118: 245-254.
25. Sumelahti ML, Tienari PJ, Wikstrom J, Palo J, Hakama M (2000) Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993. Neuroepidemiology 19: 67-75.
26. Lodi R, Montagna P, Cortelli P, Iotti S, Cevoli S, et al. (2000) 'Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. Brain 123 (Pt 9): 1896-1902.
27. Ferris SD, Sage RD, Wilson AC (1982) Evidence from mtDNA sequences that common laboratory strains of inbred mice are descended from a single female. Nature 295: 163-165.
28. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. [see comment]. Nature Genetics 26: 435-439.
29. Vogler S, Goedde R, Miterski B, Gold R, Kroner A, et al. (2005) Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclcrosis. J Mol Med 83: 806-811.
30. Vogler S, Pahnke J, Rousset S, Ricquier D, Moch H, et al. (2006) Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. American Journal of Pathology 168: 1570-1575.
31. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols.[see comment]. Annals of Neurology 13: 227-231.
32. Silander K, Axelsson T, Widen E, Dahlgren A, Palotie A, et al. (2003) Analysis of genetic variation in the GenomEUtwin project. Twin Res 6: 391-398.
33. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182.